When compared to the results obtained with a commerciallyavailable quantitative ADAMTS-13 activity ELISA, analysis of 18 plasmasamples obtained from patients with suspected TTP revealed full agreementof results with respect to the clinical 0.1 IU/mL TTP threshold. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.